Ignite Creation Date:
2025-12-25 @ 4:53 AM
Ignite Modification Date:
2026-03-13 @ 7:07 PM
Study NCT ID:
NCT03973918
Status:
TERMINATED
Last Update Posted:
2024-10-31
First Post:
2019-05-31
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ABTC 1802
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None